C
Carisma Therapeutics, Inc. (CARM)
PNK – Real Time Price. Currency in USD
0.00
0.00 (0.00%)
Market open: Aug 11, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
PNK – Real Time Price. Currency in USD
0.00
0.00 (0.00%)
Market open: Aug 11, 2026, 4:00 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Cash reserves $0.0 barely cover the upcoming debt maturities $0.0
Total current assets $0.0 are just enough to cover Total current liabilities $0.0, indicating tight liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
The company has no interest-bearing debt, showcasing excellent financial strength
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | N/A | 6.05 | 1.0 | |
| Quick ratio | N/A | 5.63 | 1.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | N/A | 1.04 | 1.0 | |
| Interest coverage | N/A | -16.91 | 10 | |
| Weighted average score | 2.8 | |||
| METRIC | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|
| Total Revenue | 10M | 15M | 20M | 45M |
| Gross Profit | 4M | 7M | 16M | -356K |
| Operating Income | -56M | -89M | -62M | 38M |
| Net Income | -61M | -87M | -60M | 35M |
| EBITDA | -50M | -80M | -59M | 38M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -100 | 33 | 5.5 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | 16.47 | 5.0 |
| Weighted average score | 3.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 557.51 | N/A | 132.32 | 7.8 |
| Y/Y | 1236.78 | 452.05 | N/A | 114.65 | 7.8 |
| 3y average | 6.79 | -6044.49 | 337.71 | -154.98 | 4.3 |
| 5y average | 231.12 | -3591.16 | 239.41 | -114.03 | 5.5 |
| Weighted average score | 6.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |